BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan X, Yu D, HuangFu M, Huang Z, Dou T, Liu Y, Zhou L, Li X, Wang L, Liu H, Wang J, Chen X. Curcumol inhibits EBV-positive Nasopharyngeal carcinoma migration and invasion by targeting nucleolin. Biochem Pharmacol 2021;192:114742. [PMID: 34428442 DOI: 10.1016/j.bcp.2021.114742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei ZL, Juan W, Tong D, Juan LX, Sa LY, Jie HFM, Xiao G, Xiang LG, Jie HM, Xu C. Curcumol inhibits breast cancer growth via NCL/ERα36 and the PI3K/AKT pathway. Food Funct 2023;14:874-85. [PMID: 36537297 DOI: 10.1039/d2fo02387c] [Reference Citation Analysis]
2 Ahmed N, Abusalah MAHA, Farzand A, Absar M, Yusof NY, Rabaan AA, AlSaihati H, Alshengeti A, Alwarthan S, Alsuwailem HS, Alrumaih ZA, Alsayyah A, Yean CY. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina (Kaunas) 2022;59. [PMID: 36676626 DOI: 10.3390/medicina59010002] [Reference Citation Analysis]
3 Ling J, Huang Y, Sun Z, Guo X, Chang A, Pan J, Zhuo X. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations. Front Pharmacol 2022;13:996728. [PMID: 36506508 DOI: 10.3389/fphar.2022.996728] [Reference Citation Analysis]
4 Zhai LY, Liu JF, Zhao JJ, Su AM, Xi XG, Hou XM. Targeting the RNA G-Quadruplex and Protein Interactome for Antiviral Therapy. J Med Chem 2022. [PMID: 35862260 DOI: 10.1021/acs.jmedchem.2c00649] [Reference Citation Analysis]
5 Wang Y, Yan Q, Mo Y, Liu Y, Wang Y, Zhang S, Guo C, Wang F, Li G, Zeng Z, Xiong W. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01502-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]